One of those arrested was a military veteran and here is what he had to say:
“I served in Afghanistan, I served in Iraq,” said Bosch. “We are fighting an army much stronger than us. The enemy is the politicians, the oligarchies. We have to do civil disobedience in order to get medical freedom. All we want to do is get something to eat and drink and we will gladly get out of here. This is what its gonna take to get America to wake up- people to sacrifice, to get comfortable with getting uncomfortable. Our time is now. This is holding the line- today. We as the people take a stand. Even if it means we go spend a little time behind bars- we will not comply. WE WILL NOT COMPLY. Medical Freedom is not negotiable. Plain and simple. NOT NEGOTIABLE. I fought for this country in order to give everybody the opportunity for freedom- and I am not going to go down. I am willing to die for my country for freedom.”
Leeroy Johnson (@LeeroyPress) Tweeted:
Protesters against mandates gather outside the 110th pct NYPD house and chant ” SHAME ON YOU NYPD ” after the NYPD arrested 5 Protesters for doing a sit in https://t.co/FgfKDcyteO
Protesters against mandates gather outside the 110th pct NYPD house and chant " SHAME ON YOU NYPD " after the NYPD arrested 5 Protesters for doing a sit in pic.twitter.com/FgfKDcyteO
As Dr. Pierre Kory, Lung Specialist and Associate Professor of Medicine at St. Luke’s Aurora Medical Center, has attested to, profound anti-viral and anti-inflammatory properties of Ivermectin have been identified.
In COVID-19 specifically, studies show that one of its several anti-viral properties is that it strongly binds to the spike protein, keeping the virus from entering the cell.
These effects, along with its multiple abilities to control inflammation, both explain the markedly positive trial results already reported.
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 “Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.
Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.”